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Background: Pluripotency of embryonic stem (ES) cells is controlled in part by chromatin-modifying factors that
regulate histone H3 lysine 4 (H3K4) methylation. However, it remains unclear how H3K4 demethylation contributes
to ES cell function.
Results: Here, we show that KDM5B, which demethylates lysine 4 of histone H3, co-localizes with H3K4me3 near
promoters and enhancers of active genes in ES cells; its depletion leads to spreading of H3K4 methylation into gene
bodies and enhancer shores, indicating that KDM5B functions to focus H3K4 methylation at promoters and enhancers.
Spreading of H3K4 methylation to gene bodies and enhancer shores is linked to defects in gene expression programs
and enhancer activity, respectively, during self-renewal and differentiation of KDM5B-depleted ES cells. KDM5B critically
regulates H3K4 methylation at bivalent genes during differentiation in the absence of LIF or Oct4. We also show that
KDM5B and LSD1, another H3K4 demethylase, co-regulate H3K4 methylation at active promoters but they retain
distinct roles in demethylating gene body regions and bivalent genes.
Conclusions: Our results provide global and functional insight into the role of KDM5B in regulating H3K4 methylation
marks near promoters, gene bodies, and enhancers in ES cells and during differentiation.Background
Embryonic stem (ES) cells express a unique network of
transcription factors (TFs) and epigenetic modifying en-
zymes that allow for indefinite self-renewal or differenti-
ation into the many cell types that exist in mammals.
The precise control of gene expression by epigenetic
regulation of transcription is important for the mainten-
ance of ES cell self-renewal or differentiation. Cell fate
decisions of ES cells are controlled in part by external
signals that regulate the expression of TFs and epigen-
etic modifiers, which in turn modify the underlying
chromatin structure in a way that is conducive or re-
pressive for transcription. ES cells express networks of
TFs, such as Oct4, Sox2, Nanog, and Tbx3 that regulate
self-renewal and differentiation by occupying promoters
and enhancers to activate gene expression of ES cell-
enriched genes and to repress developmental genes [1-3].* Correspondence: benjamin.kidder@nih.gov; zhaok@nhlbi.nih.gov
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reproduction in any medium, provided the orPerturbation of these core TFs results in the collapse of
the self-renewal network, which has been suggested to
promote differentiation [4]. While the roles of many TFs
in ES cell self-renewal have been evaluated, the functions
of epigenetic modifiers in ES cell pluripotency have not
been fully explored [5-7]. Posttranslational modification of
histone tails impacts the activity of epigenetic modifiers
and the transcriptional state (active or inactive) of the
underlying chromatin, which is important for controlling
expression of networks of genes that promote self-renewal
or differentiation.
The trithorax group (trxG) complex controls methyla-
tion of lysine 4 of histone H3 (H3K4me), which is asso-
ciated with active genes [8]. H3K4me3 is predominantly
localized to transcriptional start sites (TSSs) of highly
expressed genes [9-12] where it plays a role in RNA
polymerase II (RNAPII) binding and target gene activa-
tion [13-15]. In ES cells, methylation of H3K4me3 is
facilitated by the mammalian homolog of trxG, including
members of the Set/MLL histone methyltransferase (HMT)
family. Wdr5 is a core subunit of the MLL complexLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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renewal [5], and induced pluripotent stem (iPS) cell
reprogramming [5]. Demethylation of H3K4me3 is admin-
istered by the lysine demethylase 5 (KDM5/JARID1)
family of jumonji (J) C containing protein complexes [17].
KDM5 demethylases remove H3K4 methylation, and are
generally thought to be transcriptional repressors [18-20].
KDM5B (JARID1B) catalyzes the demethylation of tri-,
di- and mono-methylation states of H3K4, as opposed to
LSD1 (KDM1), which demethylates the di- and mono-
methylation forms of H3K4, and H3K9me2 [21].
While multiple KDM5 family demethylases recognize
similar histone modifications, each enzyme serves a unique
function by associating with different complexes and by
its mutually exclusive expression pattern throughout
development. For example, KDM5C (SMCX) associates
with HDAC1-2, G9a, and REST [22], whereas KDM5D
(SMCY) forms a complex with Ring6a (polycomb-like)
[18]. KDM5B is mainly expressed during development
and in adult tissues such as testis, thymus, brain, spleen,
and eye [23,24]. It is also highly expressed in stem cells,
including ES cells [25-27], neural progenitors [25,26],
trophoblast stem cells [28], and blood lineages [29].
Previous studies have shown that KDM5B is important
for normal embryonic development [30,31], and two
studies have described contrasting roles for KDM5B as
essential [27] or dispensable [26] for ES cell self-renewal
and differentiation. Therefore, to clarify the role of KDM5B
in regulating ES cell pluripotency, we thoroughly stud-
ied the function of KDM5B-depleted ES cells and found
that these cells have slightly reduced self-renewal and
impaired differentiation [32]. Our results also showed
that KDM5B is important for silencing pluripotency
genes during differentiation, where KDM5B-depleted
ES cells displayed extended self-renewal under differen-
tiation conditions, and an inability to fully deactivate pluri-
potency regulators [32]. We also observed underexpression
of bivalent genes during differentiation in the absence of
KDM5B, thus implicating a role for KDM5B in regulating
gene expression of bivalent genes during differentiation
[32]. These findings suggest that KDM5B plays an import-
ant role in regulating ES cell pluripotency, although the
precise role of KDM5B in regulating chromatin during this
process is not understood.
Therefore, to clarify how the regulation of H3K4 methy-
lation by the histone demethylase KDM5B contributes to
ES cell function, we investigated the genome-wide occu-
pancy of KDM5B in ES cells. Our data indicate that
KDM5B co-localizes with H3K4 methylation marks at
enhancers and promoters of active genes, functions to
focus H3K4 methylation near these regulatory regions by
preventing them from spreading to gene bodies and
enhancer shores, and is critical for enhancer activity in ES
cells. Additionally, we show that KDM5B regulates H3K4methylation at bivalent (H3K4me3/H3K27me3) develop-
mental genes during differentiation. We also report that
KDM5B and LSD1 co-regulate H3K4 methylation at
active promoter regions in ES cells, but their functions
remain distinct at bivalent developmental genes and
within gene body regions. Overall, our findings describe a
novel mechanism by which KDM5B regulates ES cell
pluripotency by modulating chromatin in a way that is
conducive for differentiation.
Results
KDM5B co-localizes with H3K4me3 and pluripotency-
related transcription factors at active genes in ES cells
We investigated the genome-wide distribution of KDM5B
binding sites in ES cells using ChIP-Seq. Our results re-
vealed that KDM5B binds to promoters, enhancers, and
gene body regions of active genes as assessed by average
profiles of KDM5B binding at transcriptional start and
end sites (TSS-TES) of active genes (Figure 1A, red line,
highest 25% expressed) and inactive genes (Figure 1A,
green line, lowest 25% expressed). A comparison of aver-
age KDM5B binding and H3K4me3 marks around TSSs
showed that KDM5B binds further downstream into gene
body regions compared with the distribution of H3K4me3
marks (Figure 1B). A more quantitative assessment of this
phenomenon revealed an increased ratio of gene body to
promoter methylation for KDM5B binding relative to
H3K4me3 marks (Figure 1C), further demonstrating
the occupancy of KDM5B in gene body regions. The
profile of KDM5B binding is similar to enrichment of
RNAPII and MLL4, which is a member of the mammalian
H3K4 histone methyltransferase complexes, near TSSs
(Figure 1D). Interestingly, KDM5B binds promoters of the
core pluripotency regulators Oct4/Pou5f1, Sox2, and
Nanog (Figure 1E), providing additional evidence that
KDM5B positively supports ES cell self-renewal. A com-
parison of KDM5B binding sites with H3K4me3 islands
revealed that >96% of KDM5B targets were enriched with
H3K4me3 (Figure 1F, left Venn diagram). These results
are in contrast to a previous study that showed KDM5B
binds predominantly intragenic regions in ES cells [27],
but are in alignment with a study that showed KDM5B
binds active genes in human cells [33]. Because many de-
velopmental genes are marked by activating H3K4me3
and repressive H3K27me3 modifications in ES cells [34],
we further compared KDM5B binding with H3K27me3-
marked genes and bivalent genes marked by H3K4me3
and H3K27me3 [35]. Our results show that KDM5B
co-localizes with 83% of H3K27me3 occupied promoters
(Figure 1F, middle Venn diagram) and 93% of bivalent
genes (Figure 1F, right Venn diagram). KDM5B co-
localizes with H3K4me3 and H3K27me3 at promoters of
bivalent developmental genes such as HoxA cluster genes
(Figure 1G). Overall, these results demonstrate that
Figure 1 KDM5B occupies active genes, pluripotency regulators, and bivalent genes in ES cells. KDM5B is associated with transcriptional
start sites (TSSs) and gene body regions of highly expressed genes in ES cells. (A) ChIP-Seq tag density of KDM5B binding at TSS normalized by
input (log2 scale) of all refseq genes sorted into quartiles based on their mRNA expression level in ES cells. (B) ChIP-Seq tag densities of KDM5B
and H3K4me3 around TSSs in ES cells. KDM5B binding profiles are similar to H3K4me3 marks near TSS regions, while KDM5B occupancy is
enriched more in gene body regions relative to H3K4me3. (C) Scatter plot of the ratio of relative tag densities of KDM5B and H3K4me3 in
promoter versus gene body regions. (D) RNA polymerase II and MLL4 are also enriched at TSS regions. (E) KDM5B occupies promoters of
pluripotency-related genes in ES cells (Pou5f1/Oct4, Sox2, and Nanog). ChIP-Seq binding profiles of KDM5B, H3K4me3, RNA polymerase II, and
Mll4 at core pluripotency genes. (F) Venn diagrams showing the co-occupancy of KDM5B and H3K4me3 (left panel), H3K27me3 (middle panel),
and both modifications (right panel) at promoter regions. (G) Example of KDM5B binding at promoters marked with H3K4me3 and H3K27me3
(for example, HoxA cluster). (H) Correlation matrix of KDM5B binding with an assortment of TFs and epigenetic modifiers that are highly
expressed in ES cells. Hierarchical clustering heat map generated by evaluating pair-wise affinities at promoters between ChIP-Seq datasets
generated from this study (KDM5B, H3K4me3, RNAPII) and from published datasets [3,35-39]. AutoSOME [40] was used to generate pair-wise
affinity values. (I) Venn diagrams showing co-occupancy of KDM5B, OCT4, SOX2, and NANOG at promoter regions.
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cluding core pluripotency-associated genes, and bivalent
genes marked by H3K4me3 and H3K27me3 in ES cells.
A further comparison of KDM5B binding profiles with
published ChIP-Seq datasets [3,35-39] revealed a strong
correlation between KDM5B binding and ES cell-enriched
TFs and histone modifications that associate with active
genes in ES cells (Figure 1H). Although KDM5B binds 83%
of H3K27me3 occupied promoters in ES cells (Figure 1F),
because this analysis compares promoter occupancy of
all genes in ES cells, KDM5B binding was not found to
be correlated with polycomb complex proteins and
H3K27me3. These results suggest that KDM5B binding is
highly correlated with H3K4me3 marks at both active
genes (for example, pluripotency regulators) and bivalent
genes. These results also show that KDM5B binding is not
correlated with H3K9me2 marks, which are associated
with inactive genes in ES cells, suggesting that KDM5B tar-
gets mainly active genes in ES cells. We further evaluated
co-binding of KDM5B and OCT4, SOX2, and NANOG
and observed a significant number of genes were co-bound
by OCT4, SOX2, and NANOG (Figure 1I).
KDM5B prevents spreading of H3K4 methylation to gene
bodies
Because KDM5B is predominantly localized near promoters
and gene body regions (Figure 1A-C), we evaluated the
regulation of H3K4 methylation profiles at these sites by
KDM5B. Interestingly, our results showed a marked increase
in global gene body methylation (H3K4me3/2) in shKdm5b
ES cells as shown in heat maps (Figure 2A) and average pro-
files (>10-fold for top 25% of H3K4me3, >3-fold for top 25%
of H3K4me2) (Figure 2B), which is correlated with gene ac-
tivity (red line indicates highest expressed genes; green line
indicates lowest expressed genes). A comparison of H3K4
methylation densities of the top 13 k expressed genes in ES
cells confirmed that Kdm5b knockdown leads to increased
H3K4me3/2 levels in gene bodies of active genes (Figure 2C),
such as LSD1/Kdm1a and Nr5a2 (Figure 2D).
We also observed decreased promoter methylation
(H3K4me3/2/1) at active genes in shKdm5b ES cells
(Figure 3A). Inspection of ChIP-Seq tracks revealed de-
creased promoter methylation at pluripotency regulators,
including Nanog, Oct4/Pou5f1, and Tbx3 (Figure 3B).
Scatter plots also highlight decreased H3K4me3/2/1 dens-
ities of highly expressed genes (Figure 3C). Overall, these
observations implicate a role for KDM5B in regulating the
localization of H3K4 methylation marks at active genes in
ES cells.
Spreading of H3K4me3 to gene bodies leads to defects in
gene expression in ES cells
Previously, we showed that KDM5B is important for ES
cell differentiation, where depletion of KDM5B results inan extension of self-renewal under differentiation condi-
tions, persistent expression of self-renewal genes, and
delayed expression of bivalent developmental genes [32].
To investigate whether the redistribution of H3K4
methylation is linked to defects in gene expression in
KDM5B-depleted ES cells, we quantified the distribution
of H3K4 methylation by calculating the relative ratio of
H3K4 methylation in gene bodies to that in promoter re-
gions, which we have termed the ‘spreading index’ (SI)
(Figure 4A). Using this calculation, we observed an in-
crease in the SI for genes marked by H3K4me3,
H3K4me2, or H3K4me1 in KDM5B-depleted ES cells
(red) relative to control ES cells (black) (Figure 4B). An
investigation of the relationship between spreading of
H3K4 methylation and gene expression in shLuc versus
shKdm5b ES cells (Figure 4C) revealed that genes with
more spreading of H3K4 methylation into gene bodies
are more sensitive to transcriptional dysregulation in
Kdm5b knockdown ES cells (Figure 4D), suggesting that
a redistribution of H3K4 methylation leads to dysregula-
tion of gene expression in KDM5B-depleted ES cells.
KDM5B prevents spreading of H3K4 methylation to
enhancer shores
Next, we investigated whether KDM5B also occupies en-
hancer regions by examining KDM5B signals at p300 bind-
ing sites, reported by others as proxies for enhancers [41],
that were sorted according to their levels of H3K27ac,
which marks active enhancers [42,43]. These results
show that KDM5B occupies active enhancers (Figure 5A;
red line, top 25% H3K27ac; green line, bottom 25%).
Concomitant with changes observed for promoter and
gene body H3K4 methylation levels following knock-
down of Kdm5b in ES cells, regions immediately adja-
cent to p300-bound regions, or p300 enhancer shores,
also contained modestly increased H3K4me3/2 and de-
creased H3K4me1 levels, as evident in heat maps (Figure 5B)
and average profiles (Figure 5C), further suggesting that
KDM5B regulates H3K4 methylation at enhancers. These
results implicate a role for KDM5B in localizing H3K4
methylation at enhancers, thereby preventing its spreading
to enhancer shores.
To determine whether spreading of H3K4 methylation
to enhancer shores leads to altered enhancer activity, we
surveyed H3K27ac levels, a hallmark of enhancer activity
[42-44], at p300 binding sites in shLuc and shKdm5b ES
cells. We observed a decrease in acetylated lysine 27 of
histone 3 (H3K27ac) levels at H3K27ac peaks (Figure 5D)
and at intergenic p300 peaks (Figure 5E) in KDM5B-
depleted ES cells, as evident in average profiles (Figure
5D,E). A scatter plot (Figure 5F) and heat maps (Figure 5G)
also reveal decreased H3K27ac densities in KDM5B-
depleted ES cells. Moreover, an investigation of the relation-
ship between spreading of H3K4 methylation and enhancer
Figure 2 KDM5B regulates H3K4 methylation at gene body regions. Knockdown of Kdm5b transcripts results in altered H3K4 methylation
profiles at promoters and enhancers and within gene body regions. (A) Heat map density of ChIP-Seq data at refseq genes sorted according to
their absolute expression in ES cells. shKdm5b ES cells exhibit increased H3K4me3/2 methylation in gene body regions and decreased H3K4me3/
2/1 methylation at promoter regions. (B) Correlation between changes in gene body histone methylation and expression level. Log2 fold change
normalized tag density ratios (shKdm5b/shLuc) of H3K4me3, H3K4me2, and H3K4me1 at all refseq genes, which were sorted into four groups
based on their absolute expression level in ES cells (red line, highest 25% expressed; green line, lowest 25% expressed). (C) Scatter plot of gene
body densities of H3K4me3/2/1 in shLuc and shKdm5b ES cells. (D) UCSC genome browser examples of altered profiles of H3K4me3/2 within
gene bodies of pluripotency-related genes such as Lsd1 and Nr5a2 in shKdm5b ES cells.
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methylation into shores in KDM5B-depleted ES cells
exhibited greater decreases in H3K27ac levels (Figure 5H).
Overall, these findings demonstrate that spreading of
H3K4 methylation to enhancer shores leads to decreased
enhancer activity, thus implicating a role for KDM5B in
regulating enhancer activity in ES cells.KDM5B regulates H3K4 methylation during ES cell
differentiation
Previous studies have shown that KDM5B is important for
differentiation [25,26,30]. It is possible that the differenti-
ation defect of KDM5B-depleted cells is due to misregula-
tion of histone methylation during early differentiation.
To test this possibility, we differentiated shKdm5b ES cells
Figure 3 KDM5B regulates H3K4 methylation at promoters. (A) Log2 normalized tag density ratios (reads per base pair per million reads
(RPBM)) of H3K4me3, H3K4me2, and H3K4me1 at TSSs of all refseq genes. (B) Browser view of altered profiles of H3K4me3/2/1 at promoters of
genes such as Nanog, Pou5f1, and Tbx3. (C) Scatter plot of ChIP-Seq tag densities of H3K4me3/2/1 peaks in promoter regions in shLuc and
shKdm5b ES cells.
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four days. While shLuc ES cell colonies became flattened
following removal of LIF, indicative of differentiation,
shKdm5b ES cells remained in a tight three-dimensional
colony formation, suggesting a resistance to changes
in cellular fate, or maintenance of self-renewal under
differentiation-inducing conditions (Figure 6A). We then
used ChIP-Seq to interrogate global H3K4 methylation
profiles during ES cell differentiation. These results dem-
onstrate that shKdm5b ES cells exhibit decreased pro-
moter H3K4 methylation and increased gene body H3K4
methylation at highly expressed ES cell genes during dif-
ferentiation (Figure 6B). This pattern is consistent with
the effects of Kdm5b knockdown on H3K4 methylation
profiles in ES cells under self-renewing conditions. While
H3K4 methylation was downregulated at promoters of
most self-renewal genes (for example, Pou5f1, Nanog) dur-
ing shKdm5b ES cell differentiation, H3K4 methylation
was not equally downregulated at several self-renewal
genes, such as Tbx3 (Figure 6C), relative to shLuc ES cells,
which may in part explain the delayed differentiation of
shKdm5b ES cells. KDM5B binding in ES cells overlapswith H3K4 methylation changes observed during differen-
tiation (Figure 6C, top track). However, because shKdm5b
ES cells exhibit depleted H3K4 methylation at promoter
regions under self-renewing conditions, and continue to
self-renew, albeit at a reduced pace, changes in global pro-
moter H3K4 methylation may not alone explain the de-
layed differentiation ability of shKdm5b ES cells.
To further understand epigenetic changes resulting
from Kdm5b knockdown, we evaluated H3K4 methyla-
tion at p300 enhancers during ES cell differentiation.
Interestingly, p300-bound enhancers showed similar
patterns of H3K4 methylation during differentiation
(day 4) relative to ES cells grown under self-renewing
conditions (Figure 6D), which is also consistent with
the trend observed at promoter regions. Because ES cell
differentiation is a dynamic process involving epigenetic
alterations to chromatin and transcriptional changes, to
further understand the role of KDM5B in differenti-
ation we surveyed changes in H3K4 methylation at key
developmental genes during shKdm5b ES cell differen-
tiation. Interestingly, promoter H3K4me3 levels de-
creased on a global level following three days of ES cell
Figure 4 Spreading of H3K4me3 to gene bodies leads to defects in gene expression in ES cells. (A) Schematic representation describing
the calculation used to determine the SI of genes marked by H3K4 methylation. The promoter bin is defined as a 1 kb, 1.5 kb, or 3 kb window
around the TSS of genes marked by H3K4me3, H3K4me2, and H3K4me1, respectively, while the transcribed region (gene body) is defined as
the region extending to the TES. The SI is calculated from the ratio of the density of H3K4 methylation in the gene body bin to the density of
H3K4 methylation in the promoter bin. (B) Empirical cumulative distribution for the SI of H3K4me3 (top panel), H3K4me2 (middle panel), and
H3K4me1 (bottom panel) across all genes for shLuc (black) and shKdm5b (red) ES cells. Y-axis shows the percentage of genes that exhibit a SI
less than the value specified by the x-axis. A line shifted to the right means a systematic increase in the spreading index. P-value for all <1E-5
(Kolmogorov-Smirnov test). Note the increased SI for genes marked by H3K4me3, H3K4me2, and H3K4me1 in shKdm5b ES cells. (C) Scatter plot
of gene expression measured by RPKM (reads per kilobases of exon model per million reads). Log2-adjusted differentially expressed (DE) genes
(>1.5-fold; false discovery rate <0.001; RPKM >11) are shown in black. (D) Spreading of H3K4 methylation into gene bodies is associated with
defects in gene expression in Kdm5b knockdown ES cells. Genes are ordered on the x-axis from left to right based on the fold change in their
SI (shKdm5b/shLuc; ES cells) from low to high. A sliding window of 1,000 genes was used to calculate the percentage of DE genes (y-axis). The
analysis was performed independently using SIs calculated for H3K4me3 (red), H3K4me2 (green), and H3K4me1 (blue) marks.
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served in other recent ES cell time-course differenti-
ation reports [45,46]. However, knockdown of Kdm5b
led to persistence of H3K4me3 signals at a subset of
genes bound by KDM5B in ES cells (Figure 6F, top
tracks), including HoxA cluster genes and other devel-
opmental genes such as Cdx2 (Figure 6F) during three
to four days of ES cell differentiation.To investigate whether KDM5B particularly impacts
H3K4me3 at bivalent genes (marked by H3K4me3/
H3K27me3) in differentiated shKdm5b ES cell, we ranked
genes according to their change in H3K4me3 level within
promoter regions following knockdown of Kdm5b and
evaluated the percentage of bivalent genes using a sliding
window of 500 genes (Figure 7A). The analysis revealed
that a greater percentage of bivalent genes exhibited
Figure 5 (See legend on next page.)
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Figure 5 KDM5B controls enhancer activity by regulating H3K4 methylation. (A) KDM5B binding at p300 enhancer sites sorted by
enrichment level of acetylated H3K27 (H3K27ac). (B) Heat map density profiles of H3K4me3/2/1 around intergenic p300 binding sites, sorted by
H3K27ac levels. (C) Top: average profile of H3K4me3/2/1 density at intergenic p300 sites in shLuc and shKdm5b ES cells. Bottom: log2 fold
change normalized tag density ratios (shKdm5b/shLuc) of H3K4me3, H3K4me2, and H3K4me1 at p300 enhancers. RPBM, reads per base pair per
million reads. (D) Average profiles of H3K27ac tag densities around H3K27ac peaks in shLuc and shKdm5b ES cells. (E) Average profiles of
H3K27ac tag densities of H3K27ac around p300 binding sites (proxies of enhancers) in shLuc and shKdm5b ES cells. (F) Scatter plot of H3K27ac
tag densities in shLuc and shKdm5b ES cells. (G) Heat map density profiles of H3K27ac peaks, sorted by H3K27ac levels. (H) Spreading of H3K4
methylation into enhancer shores in Kdm5b knockdown ES cells is associated with a decrease in H3K27ac levels. Shown are empirical cumulative
distributions for the change in H3K27ac (shKdm5b/shLuc) across two groups of enhancers sorted by changes in spreading indices, calculated
independently for H3K4me3 (left panel), H3K4me2 (middle panel) or H3K4me1 (right panel). Y-axis shows the percentage of enhancers that ex-
hibit a change in H3K27ac density less than the value specified by the x-axis. A line shifted to the left means a systematic decrease in H3K27ac
levels. P-value for all <1E-5 (Kolmogorov-Smirnov test).
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ation relative to genes with decreased H3K4me3 levels
(Figure 7A), suggesting that KDM5B plays a critical role in
erasing H3K4me3 at bivalent genes during ES cell differ-
entiation. The TSS-TES profiles of genes with increased
H3K4me3 are shown in Figure 7B. To confirm these re-
sults in another differentiation context, we forced the
differentiation of ES cells by depleting OCT4 levels using
the Oct4-regulatable ES cell line ZHBTc4 [47] in combin-
ation with RNA interference-mediated reduction of Kdm5b
transcripts as described above, and subsequently per-
formed ChIP-Seq to evaluate global H3K4me3 levels. In
the presence of OCT4 and LIF, the phenotype of shKdm5b
ZHBTc4 ES cells relative to shLuc ZHBTc4 ES cells is simi-
lar to the phenotype of KDM5B-depleted ES cells as de-
scribed above, where shKdm5b ZHBTc4 ES cells have a
slightly reduced colony size (Figure 7C, top). Following
two days of OCT4 depletion in the presence of doxycycline
(Figure 7C, bottom), we observed global decreases in
H3K4me3 levels, which was similar to our previous results
following differentiation in the absence of LIF. Moreover,
we also observed a greater percentage of bivalent genes,
including Hox genes, with elevated H3K4me3 levels
following differentiation of shKdm5b ZHBTc4 ES cells
(Figure 7D,E). To understand if this pattern is unique to
promoter regions, we also investigated changes in
H3K4me3 levels within gene body regions of bivalent
genes in shKdm5b ES cells. Interestingly, while we ob-
served a greater percentage of bivalent genes with de-
creased H3K4me3 in gene bodies prior to differentiation,
this differential methylation decreased somewhat during
differentiation (Figure 7F), suggesting that gene body
methylation is not as resistant to changes in H3K4me3
levels at bivalent genes relative to promoter regions. Be-
cause expression of self-renewal genes is normally discon-
tinued during differentiation, demethylation of gene body
regions is not likely to play a predominant role in turning
over expression programs relative to promoter deactiva-
tion. Overall, these results suggest that KDM5B demethy-
lates bivalent genes during differentiation, where ES cells
lacking KDM5B are unable to efficiently reset the self-renewal epigenetic landscape and adequately establish a
new expression paradigm to facilitate differentiation.
Spreading of H3K4me3 to gene bodies leads to defects in
gene expression during ES cell differentiation
Our results demonstrate that KDM5B occupies bivalent
genes in ES cells, and depletion of KDM5B leads to un-
derexpression of bivalent developmental genes during
ES cell differentiation [32], spreading of H3K4 methyla-
tion to gene bodies during differentiation, and persistent
H3K4me3 marks at bivalent genes during differentiation.
To investigate a correlation between changes in H3K4
methylation levels at gene body and promoter regions,
and gene expression changes during differentiation of
KDM5B-depleted ES cells, we first used RNA-Seq data
to identify differentially expressed genes (fold change >1.5;
false discovery rate (FDR) <0.001; RPKM (reads per
kilobases of exon model per million reads) >1) during
differentiation in the absence of KDM5B for two days
(48 h; Figure 8A) and three days (72 h; Figure 8B). We
then characterized H3K4 methylation in gene body and
promoter regions using the SI (Figure 4A). Using this
metric, we observed an increase in the SI for genes
marked by H3K4me3, H3K4me2, or H3K4me1 follow-
ing three days of differentiation of KDM5B-depleted ES
cells (red) relative to control ES cells (black) (Figure 8C).
An investigation of the relationship between spreading of
H3K4 methylation and gene expression revealed that
genes with greater spreading of H3K4 methylation into
gene bodies are more sensitive to transcriptional dysreg-
ulation during differentiation of Kdm5b knockdown ES
cells (Figure 8D). These findings suggest that a redistri-
bution of H3K4 methylation leads to dysregulation of
gene expression during differentiation of KDM5B dep-
leted ES cells.
KDM5B and LSD1 co-regulate H3K4 methylation in
ES cells
In addition to KDM5B, LSD1 (KDM1A) also regulates
H3K4 methylation [21] and critically contributes to em-
bryo development and ES cell pluripotency [48-51]. To
Figure 6 KDM5B regulates H3K4 methylation during differentiation. (A) ES cells cultured in the absence of LIF for 3 to 4 days to induce
differentiation. Note the loss of normal three-dimensional colony morphology of shLuc ES cells at day 3 of differentiation, while shKdm5b ES cells
maintained their normal three-dimensional colony morphology in the absence of LIF. (B) Correlation between changes in histone methylation
and expression level. Fold change normalized tag density ratios (shKdm5b/shLuc) of H3K4me3, H3K4me2, and H3K4me1 at all refseq genes, which
were sorted into three groups based on their expression level (red line, highest expressed; green line, lowest expressed). (C) UCSC genome
browser view of H3K4me3/2/1 marks at the self-renewal gene Tbx3 during differentiation. shKdm5b ES cells have altered H3K4me3/2/1 levels
relative to shLuc ES cells. (D) Average profile of H3K4me3/2/1 densities at p300 enhancer regions following 4 days of shLuc and shKdm5b ES cell
differentiation. RPBM, reads per base pair per million reads. (E) Promoter density of H3K4me3 in ES cells and day 3 differentiated ES cells. (F) UCSC
browser view of H3K4me3 density at HoxA cluster genes during differentiation. Note the delayed decrease of H3K4me3 levels during shKdm5b
ES cell differentiation relative to shLuc ES cells.
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Figure 7 KDM5B regulates H3K4 methylation at bivalent genes during differentiation without LIF and Oct4. (A) Relationship between
changes in promoter H3K4me3 density during differentiation and the percentage of genes with bivalent marks (H3K4me3/H3K27me3), using
a sliding window of 500 genes (red, increased H3K4me3; black, no-change in H3K4me3; green, decreased H3K4me3). (B) Average profile
of H3K4me3 density at genes with increased H3K4me3 during shKdm5b differentiation. RPBM, reads per base pair per million reads.
(C) Oct4-regulatable ES cells (ZHBTc4) infected with shLuc or shKdm5b lentiviral particles were (D) cultured in the presence of doxycycline to
downregulate OCT4 levels and induce differentiation. Relationship between changes in promoter H3K4me3 density during differentiation in the
absence of OCT4 and KDM5B and the percentage of genes with bivalent marks (red, increased H3K4me3; black, no-change in H3K4me3; green,
decreased H3K4me3). (E) Browser view of H3K4me3 density following differentiation of shKdm5b ZHBTc4 ES cells. (F) Relationship between
changes in gene body H3K4me3 density during differentiation and the percentage of genes with bivalent marks.
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in regulating ES cell chromatin, we compared the genome-
wide binding of KDM5B and LSD1 [39] and found that
they co-occupy 6,123 genes in ES cells (Figure 9A),
which comprises 79% of LSD1 targets and 45% of KDM5B
targets. To investigate the function of LSD1 in regulating
H3K4 methylation, we treated ES cells with the LSD1 in-
hibitor tranylcypromine (parnate/TCP (LSD1i)) (Figure 9B),
and evaluated the global distribution of H3K4 methyla-
tion using ChIP-Seq (Figure 9C). Although treatment
with LSD1i resulted in modest changes in cellular morph-
ology (Figure 9B), inhibition of LSD1 resulted in decreased
H3K4 promoter methylation of highly expressed genes
and increased H3K4 methylation in gene body regions
of lowly expressed genes as shown in average profiles
(>5-fold for bottom 25% of H3K4me3, >3-fold for bottom
25% of H3K4me2) (Figure 9C). Increased gene bodymethylation is also visible in genome tracks of H3K4
methylation at lowly expressed olfactory receptor genes
(Figure 10A). Moreover, a combined inhibition of LSD1
and Kdm5b knockdown resulted in greater decreases in
H3K4me3/2/1 levels at active promoters (for example,
Nanog, Pou5f1) relative to treatment with LSD1i or
Kdm5b knockdown alone (Figure 10B,C). These differ-
ences are evident in average profile graphs (Figure 9C)
and browser views (Figure 10B), where H3K4me2 has
been reduced to near baseline upon LSD1 inhibition and
Kdm5b knockdown, and density scatter plots (Figure 10C).
However, simultaneous inhibition of LSD1 and Kdm5b
knockdown did not augment H3K4 methylation levels in
gene body regions, which we observed in shKdm5b ES
cells, suggesting that LSD1 and KDM5B serve unique
functions in ES cells. While both KDM5B and LSD1 regu-
late H3K4 methylation levels at promoters, our results
Figure 8 Spreading of H3K4me3 to gene bodies leads to defects in gene expression during ES cell differentiation. Scatter plot of gene
expression measured by RPKM for shLuc and shKdm5b ES cells differentiated in the absence of LIF for (A) 48 h (day 2) and (B) 72 h (day 3).
Log2-adjusted differentially expressed genes (>1.5-fold; FDR <0.001; RPKM >1) are shown in black. (C) Empirical cumulative distribution for the
spreading index of H3K4me3 (top panel), H3K4me2 (middle panel), and H3K4me1 (bottom panel) across all genes for shKdm5b knockdown cells
(red line) and shLuc control cells (black line) following differentiation for three days after LIF withdrawal. Y-axis shows the percentage of genes
that exhibit a spreading index less than the value specified by the x-axis. A line shifted to the right means a systematic increase in the spreading
index. P-value for all <1E-5 (Kolmogorov-Smirnov test). (D) Spreading of H3K4me into gene body regions is associated with defects in gene
expression during differentiation of KDM5B-depleted ES cells. Genes were ordered on the x-axis from left to right based on the fold change in
their SI (shKdm5b/shLuc) from low to high. A sliding window of 1,000 genes was used to calculate the percentage of differentially expressed (DE)
genes (y-axis) in KDM5B-depleted cells. The analyses were performed independently using SIs calculated from H3K4me3 (top panel), H3K4me2
(middle panel), and H3K4me1 (bottom panel) marks following two and three days of ES cell differentiation after LIF withdrawal.
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Figure 9 KDM5B and LSD1 co-regulate H3K4 methylation in ES cells. (A) Venn diagram showing overlap of KDM5B- and LSD1-bound genes
in ES cells. (B) Bright field microscopy of shLuc and shKdm5b ES cells cultured in the presence of 2 μM of the LSD1 inhibitor tranylcypromine/
parnate (LSD1i) for 4 days. (C) Correlation between changes in histone methylation and expression level. Fold change normalized tag density ratios of
H3K4me3, H3K4me2, and H3K4me1 at refseq genes were sorted into four groups based on their absolute expression level. Note that the lowest
expressed genes have increased H3K4me3/2/1 levels in LSD1i-treated ES cells (red line, highest 25% expressed; green line, lowest 25% expressed).
Kidder et al. Genome Biology 2014, 15:R32 Page 13 of 19
http://genomebiology.com/2014/15/2/R32demonstrate that KDM5B demethylates gene body regions
of active genes while LSD1 demethylates gene body re-
gions of inactive genes in ES cells.
We also observed altered H3K4 methylation levels at
enhancer regions marked by p300 binding upon inhibition
of LSD1 (Figure 11A). Inhibition of LSD1 resulted indecreased H3K4me3/2/1 levels at p300 enhancers, while
enhancer shores showed modest increases in H3K4me3/2
levels, suggesting that KDM5B and LSD1 both regulate
H3K4 methylation at enhancer regions. Intriguingly, we
found decreased H3K4 methylation levels at bivalent
genes in LSD1i ES cells, including HoxA cluster genes,
Figure 10 H3K4 methylation profiles in KDM5B-depleted and LSD1-inhibited ES cells. Browser views of H3K4me3/2/1 densities at (A)
olfactory receptor and (B) pluripotency genes (Nanog, Pou5f1). (C) Fold change densities of H3K4me3/2/1 peaks in shLuc + LSD1i and shKdm5b +
LSD1i ES cells relative to shLuc ES cells. RPBM, reads per base pair per million reads.
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the Kdm5b knockdown cells. By ranking genes according
to their change in H3K4me3 level (shLuc LSD1i versus
shLuc) within promoter regions and evaluating the per-
centage of bivalent genes using a sliding window of 500
genes, we observed a greater percentage of bivalent geneswith decreased H3K4me3 following LSD1 inhibition rela-
tive to genes with increased H3K4me3 levels (Figure 11B),
suggesting that bivalent genes are unable to maintain
H3K4 methylation levels following inhibition of LSD1.
Specifically, we observed decreased H3K4me3 levels at
Hox genes (Figure 11C). In summary, these results
Figure 11 KDM5B and LSD1 regulate H3K4 methylation at promoters and enhancers in ES cells. (A) Average profile of H3K4me3/2/1
density at p300 enhancer regions in LSD1i-treated ES cells (red line) relative to shLuc ES cells (black line). RPBM, reads per base pair per million
reads. (B) Relationship between changes in promoter and gene body H3K4me3 density and the percentage of genes with bivalent marks (red,
increased H3K4me3; black, no-change in H3K4me3; green, decreased H3K4me3). (C) Genome browser view of H3K4me3 levels at HoxA cluster
bivalent genes upon inhibition of LSD1 in ES cells.
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at bivalent genes, where KDM5B is dispensable for
maintaining H3K4 methylation at bivalent genes while
LSD1 is involved in maintaining H3K4 methylation in
ES cells.
Discussion
KDM5B regulates H3K4 methylation in gene bodies and
enhancer shores
Epigenomic analysis of KDM5B binding and H3K4
methylation upon depletion of KDM5B revealed its glo-
bal targets and core function. We found that KDM5B
binds to promoters and gene bodies of active genes,
enhancers, and co-localizes with H3K4me3 marks and
core pluripotency TFs (Figure 1H). As expected, Kdm5b
knockdown led to a net gain of H3K4me3/2 as assessed
by western blotting [32], although we did not observe
significant changes in the global levels of H3K4me1 in
Kdm5b knockdown ES cells (Additional file 1). However,
Kdm5b knockdown led to a striking redistribution of
H3K4 methylation, including global increases withingene body regions (Figure 2) and decreases in promoters
of highly active genes (Figure 3), which were correlated
with changes in gene expression in ES cells (Figure 4D).
There are several possible explanations for this phe-
nomenon. First, our data show that KDM5B binding
is highly enriched at TSS regions (Figure 1A), but
KDM5B binds further downstream into gene body re-
gions compared with the distribution of H3K4me3
marks (Figure 1B). KDM5B may prevent spreading of
H3K4 methylation to gene body regions by resetting
H3K4 methylation after each transcriptional cycle, or
upon gene activation, which has been suggested previously
in a different context for histone deacetylase activity
[52,53]. An inability to properly reset H3K4 methylation
levels may lead to skewed H3K4 methylation profiles,
including decreased levels at promoters. To facilitate
gene body demethylation, KDM5B may associate with
unphosphorylated RNAPII, initiated RNAPII (Ser5P), or
elongating RNAPII (Ser2P) in a manner analogous to the
association of components of the MLL methyltransferase
complex, WDR5 and ASH2L, with RNAPII Ser2P or
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demethylases with partially overlapping or redundant
functions may compensate for the depletion of KDM5B,
leading to decreased H3K4 demethylation at promoters.
While we did not observe differential expression of other
demethylases in the absence of KDM5B, our data show
that a combined depletion of KDM5B and inhibition of
LSD1 in ES cells leads to greater decreases in H3K4me3/2
levels at promoters compared with individual perturbation
of Kdm5b or LSD1 (Figure 10B,C). Third, KDM5B may
associate with H3K4 methyltransferases to reinforce their
activity or promote their recruitment to promoter regions.
In this case, depletion of KDM5B may lead to decreased
promoter H3K4 methylation and aberrant H3K4 methlya-
tion in gene bodies due to deficiencies in recruitment
or activity. Fourth, KDM5B-mediated demethylation of
promoter-adjacent regions may allow for focused, or sharp,
H3K4 methylation peaks near TSS regions, thus serving
as a platform for RNAPII binding [9,54] and recognition
by H3K4 methyltransferases (for example, MLL/trxG
proteins). In the absence of KDM5B, H3K4 methylation
spreading to gene bodies may lead to aberrant H3K4
methylation by methyltransferases as a result of a diffuse
H3K4 methylation platform to target.
Our finding that KDM5B demethylates gene body
regions is partially in alignment with a previous study
suggesting that KDM5B removes local domains of intra-
genic H3K4me3 [27]. However, while we observed global
increases in H3K4 methylation (H3K4me3, H3K4me2)
in gene body regions of active genes, including pluripo-
tency regulators, in KDM5B-depleted ES cells, it is
unclear from the Xie et al. study [27] whether depletion
of KDM5B leads to global changes in H3K4 methylation
levels. Also, Xie et al. suggest that KDM5B binds pre-
dominantly intragenic regions, which is in contrast to
our findings and results presented in another previous
study examining KDM5B binding in human cells [33],
both of which demonstrate that KDM5B binding is
highly correlated with H3K4me3 marks at active promoters.
We also observed similar changes in H3K4 methyla-
tion at enhancer sites compared with promoters follow-
ing knockdown of Kdm5b, including decreased levels at
p300 enhancer peaks and increased levels at neighboring
regions, providing further evidence that KDM5B func-
tions to focus H4K4 methylation. Our results also reveal
that KDM5B-depleted ES cells have decreased enhancer
activity, as measured by H3K27ac levels (Figure 5D-G),
demonstrating that KDM5B is important in regulating
enhancer function in ES cells. Increased H3K4 methyla-
tion in gene bodies and enhancer shores may support
delayed differentiation by providing a broader platform
for recognition by transcriptional machinery, thus re-
inforcing expression of self-renewal genes. It is likely
that shKdm5b ES cells fail to properly differentiate dueto a combination of inefficient deactivation of self-
renewal genes and activation of differentiation genes.
KDM5B regulates H3K4 methylation during differentiation
Our results also support a role for KDM5B in regulating
H3K4 methylation at developmental genes during differen-
tiation. Previous studies have shown that lineage-specific
genes are underexpressed following EB differentiation of
KDM5B-depleted ES cells [25-27]. These studies under-
score the importance of KDM5B for differentiation. We
found that shKdm5b ES cells retain higher levels of
H3K4me3 at bivalent genes during differentiation com-
pared to shLuc ES cells. The delayed differentiation of
KDM5B-depleted ES cells may be due to the inability to ef-
ficiently remove H3K4 methylation marks at bivalent genes
during differentiation, which may be required to reset the
underlying epigenetic profile. While bivalent genes have
been reported to maintain H3K4me3 marks at similar
levels between ES cells and differentiated cells at key devel-
opmental genes [34,35,38], the levels of these marks during
differentiation have not been fully addressed. We show
that H3K4me3 levels initially decrease at self-renewal and
bivalent genes during early differentiation. H3K4 methyla-
tion levels are then re-established upon lineage commit-
ment. Our results describing global decreases in H3K4me3
during differentiation are supported by two recent studies
[45,46]. The initial depletion of H3K4me3 at developmen-
tal genes during differentiation underscores an intriguing
and underexplored regulatory aspect of this mark during
lineage commitment. We also demonstrate that spreading
of H3K4 methylation to gene bodies leads to differential
gene expression during differentiation (Figure 8D). Alto-
gether, these findings provide novel insights into the role of
H3K4me3 marks at bivalent developmental genes during
differentiation.
Similarities and differences between KDM5B and LSD1
Our results demonstrate that KDM5B and LSD1 co-
regulate H3K4 methylation at promoters of highly active
genes, where knockdown of Kdm5b or inhibition of LSD1
resulted in decreased H3K4 methylation (Figure 3A-C,
Figure 10B-C). Moreover, combined knockdown of Kdm5b
and inhibition of LSD1 led to a near complete loss of
H3K4me2 at promoters (Figure 9C, middle panel). How-
ever, H3K4me3/1 levels were not reduced to the same
degree at these sites, suggesting that KDM5B and LSD1
serve distinct roles in regulating tri-, di-, and mono-
methylation states at promoters. This is consistent with
the respective substrate specificities of these enzymes,
where KDM5B demethylates H3K4me3/2/1 while LSD1
demethylates H3K4me2/1.
KDM5B and LSD1 also differentially regulate H3K4
methylation at bivalent genes. While Kdm5b knockdown
led to increased or unaltered H3K4me3 levels at bivalent
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creased H3K4 methylation levels. KDM5B and LSD1
also differ in their regulation of H3K4 methylation
within gene body regions, where KDM5B demethylates
gene bodies of active genes (Figure 2) while LSD1
demethylates gene bodies of inactive genes (Figure 9C).
Demethylation of gene bodies may serve to focus H3K4
methylation near promoters and enhancers, thus pre-
venting the spread of methylation into surrounding nu-
cleosomes. Alternatively, demethylation of gene body
regions may also serve to reset nucleosome methylation
after RNAPII mediated transcription.
Conclusions
Data presented here provide novel insight into epige-
nomic regulation of H3K4 methylation in ES cells, where
KDM5B functions to focus H3K4 methylation near pro-
moters and enhancers to prevent the spread of these
marks to surrounding regions.
Materials and methods
Embryonic stem cell culture
R1 ES cells, obtained from ATCC (Manassas, VA, USA),
were cultured as previously described with minor modi-
fications [55]. Briefly, R1 ES cells were cultured on irra-
diated mouse embryonic fibroblasts in DMEM/15% fetal
bovine serum media containing LIF (ESGRO, EMD
Millipore, Billerica, MA, USA) at 37°C with 5% CO2. For
chromatin immunoprecipitation (ChIP) experiments, ES
cells were cultured on gelatin-coated dishes in ES cell
media containing 1.5 μM CHIR9901 (GSK3 inhibitor)
for several passages to remove feeder cells. ES cells were
passed by washing with phosphate-buffered saline, and
dissociating with trypsin. For LSD1 inhibition experi-
ments, ES cells were cultured in the presence of 2 μM
TCP/parnate (LSD1i) for 48 h. For differentiation experi-
ments in the absence of OCT4, ZHBTc4 ES cells [47]
were infected with shLuc or shKdm5b lentiviral particles
and selected in the presence of 2 μg/ml puromycin.
shLuc and shKdm5b ZHBTc4 ES cells were cultured in
the presence of 2 μg/ml doxycycline for 48 h to down-
regulate OCT4 expression. For differentiation experie-
ments in the absence of LIF, ES cells were cultured on
gelatin coated dishes or low-attachment binding dishes
to promote three-dimensional formation in ES cell
medium without LIF.
Lentiviral infection
Short hairpin RNAs (shRNAs) were cloned into the
pGreenPuro Vector (System Biosciences, Mountain View,
CA, USA) according to the manufacture’s protocol. To
generate lentiviral particles, 293 T cells were co-
transfected with an envelope plasmid (plpVSVG), pack-
aging vector (psPAX2), and shRNA expression vectorusing lipofectamine 2000. The medium containing lenti-
viral particles was harvested 24 to 48 h post-transfection
and used to transduce ES cells. ES cells at 24 h post-
transduction were stably selected in the presence of 1 to
2 μg/ml puromycin.
ChIP-Seq analysis
ChIP-Seq experiments were performed as previously de-
scribed with minor modifications [32]. The polyclonal
KDM5B (ab50958), monoclonal H3K4me2 (ab32356),
and polyclonal H3K4me1 (ab8895) antibodies were ob-
tained from Abcam (Cambridge, MA, USA). The mono-
clonal H3K4me3 antibody (CS200580) was obtained from
EMD Millipore. Briefly, 107 to 108 mouse ES cells (R1 or
ZHBTc4) were harvested and chemically crosslinked with
1% formaldehyde (Sigma-Aldrich, St. Louis, MO, USA)
for 5 to 10 minutes at 37°C and subsequently sonicated.
Sonicated cell extracts equivalent to 2 × 106 cells were
used for ChIP assays. ChIP-enriched DNA was end-
repaired using the End-It DNA End-Repair kit (Epicentre,
Charlotte, NC, USA), followed by addition of a single A
nucleotide, and ligation of PE adapters (Illumina, San
Diego, CA, USA) or custom indexed adapters. PCR was
performed using Phusion High Fidelity PCR master mix.
ChIP libraries were sequenced on Illumina GAIIX or
HiSeq platforms according to the manufacture’s protocol.
Sequence reads were mapped to the mouse genome
(mm8) by bowtie [56] with settings eliminating reads
mapped to multiple genomic sites. ChIP-Seq read
enriched regions were identified by SICER [57] with a
window size setting of 200 bp, a gap setting of 400 bp
and a FDR setting of 0.001. For TFs, the ChIP-Seq read-
enriched peaks were called by MACS [58] with a P-value
setting of 0.00001.
RNA-Seq analysis
Poly-A mRNA was purified using a Dynabeads mRNA
purification kit (Life Technologies, Grand Island, NY,
USA). Double-stranded cDNA was generated using a
Super-Script double-stranded cDNA synthesis kit (Life
Technologies). cDNA was subjected to library prepar-
ation as described above. RNA-Seq libraries were se-
quenced on an Illumina GAIIX or HiSeq platform
according to the manufacturer’s protocol.
The RPKM measure (reads per kilobases of exon
model per million reads) [59] was used to quantify the
mRNA expression level of a gene from RNA-Seq data.
Differentially expressed genes were identified using
edgeR (FDR <0.001; fold change >1.5) [60].
Accession number
The sequencing data from this study have been submit-
ted to the NCBI Gene Expression Omnibus (GEO) [61]
under accession number GSE53093 [62].
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Additional file 1: Figure S1. Western blot of H3K4me1 in shLuc and
shKdm5b ES cells. shLuc and shKdm5b ES cells were cultured without
feeders in the presence of LIF, lysed, and subjected to western blotting
for H3K4me1 using standard protocols.
Abbreviations
bp: base pair; ChIP: chromatin immunoprecipitation; ES: embryonic stem;
FDR: false discovery rate; H3K4: lysine 4 of histone H3; LSD1i: LSD1 inhibitor
tranylcypromine; RNAPII: RNA polymerase II; RPKM: reads per kilobases of
exon model per million reads; shRNA: small hairpin RNA; SI: spreading index;
TCP: tranylcypromine; TEF: transcriptional end site; TF: transcription factor;
TSS: transcriptional start site.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
BK conceived of the study, designed and carried out the experiments,
analyzed the sequencing data, and drafted the manuscript. GH helped to
analyze the sequencing data and draft the manuscript. KZ participated in the
design of the study and helped to draft the manuscript. All authors have
read and approved the final version of this manuscript.
Acknowledgements
This work was supported by the Division of Intramural Research of the
National Heart, Lung and Blood Institute. The DNA Sequencing Core facility
of NHLBI assisted with this work.
Received: 14 August 2013 Accepted: 4 February 2014
Published: 4 February 2014
References
1. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG,
Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young
RA: Core transcriptional regulatory circuitry in human embryonic stem
cells. Cell 2005, 122:947–956.
2. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, Bourque G, George J,
Leong B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L,
Kuznetsov VA, Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH:
The Oct4 and Nanog transcription network regulates pluripotency in
mouse embryonic stem cells. Nat Genet 2006, 38:431–440.
3. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang
W, Jiang J, Loh YH, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B,
Shahab A, Ruan Y, Bourque G, Sung WK, Clarke ND, Wei CL, Ng HH:
Integration of external signaling pathways with the core transcriptional
network in embryonic stem cells. Cell 2008, 133:1106–1117.
4. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y,
Lemischka IR: Dissecting self-renewal in stem cells with RNA interference.
Nature 2006, 442:533–538.
5. Ang YS, Tsai SY, Lee DF, Monk J, Su J, Ratnakumar K, Ding J, Ge Y, Darr H,
Chang B, Wang J, Rendl M, Bernstein E, Schaniel C, Lemischka IR: Wdr5
mediates self-renewal and reprogramming via the embryonic stem cell
core transcriptional network. Cell 2011, 145:183–197.
6. Pasini D, Cloos PA, Walfridsson J, Olsson L, Bukowski JP, Johansen JV, Bak M,
Tommerup N, Rappsilber J, Helin K: JARID2 regulates binding of the
Polycomb repressive complex 2 to target genes in ES cells. Nature 2010,
464:306–310.
7. Boyer LA, Plath K, Zeitlinger J, Brambrink T, Medeiros LA, Lee TI, Levine SS,
Wernig M, Tajonar A, Ray MK, Bell GW, Otte AP, Vidal M, Gifford DK, Young
RA, Jaenisch R: Polycomb complexes repress developmental regulators in
murine embryonic stem cells. Nature 2006, 441:349–353.
8. Ringrose L, Paro R: Epigenetic regulation of cellular memory by the
Polycomb and Trithorax group proteins. Annu Rev Genet 2004,
38:413–443.
9. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I,
Zhao K: High-resolution profiling of histone methylations in the human
genome. Cell 2007, 129:823–837.10. Schubeler D, MacAlpine DM, Scalzo D, Wirbelauer C, Kooperberg C,
van Leeuwen F, Gottschling DE, O'Neill LP, Turner BM, Delrow J, Bell SP,
Groudine M: The histone modification pattern of active genes revealed
through genome-wide chromatin analysis of a higher eukaryote.
Genes Dev 2004, 18:1263–1271.
11. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW,
Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK,
Young RA: Genome-wide map of nucleosome acetylation and
methylation in yeast. Cell 2005, 122:517–527.
12. Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y,
Green RD, Ren B: A high-resolution map of active promoters in the
human genome. Nature 2005, 436:876–880.
13. Sims RJ 3rd, Nishioka K, Reinberg D: Histone lysine methylation: a
signature for chromatin function. Trends Genet 2003, 19:629–639.
14. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC,
Schreiber SL, Mellor J, Kouzarides T: Active genes are tri-methylated at K4
of histone H3. Nature 2002, 419:407–411.
15. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides
T: Histone H3 lysine 4 methylation patterns in higher eukaryotic genes.
Nat Cell Biol 2004, 6:73–77.
16. Wysocka J, Swigut T, Milne TA, Dou Y, Zhang X, Burlingame AL, Roeder RG,
Brivanlou AH, Allis CD: WDR5 associates with histone H3 methylated at
K4 and is essential for H3 K4 methylation and vertebrate development.
Cell 2005, 121:859–872.
17. Mosammaparast N, Shi Y: Reversal of histone methylation: biochemical
and molecular mechanisms of histone demethylases. Annu Rev Biochem
2010, 79:155–179.
18. Lee MG, Wynder C, Bochar DA, Hakimi MA, Cooch N, Shiekhattar R:
Functional interplay between histone demethylase and deacetylase
enzymes. Mol Cell Biol 2006, 26:6395–6402.
19. Klose RJ, Zhang Y: Regulation of histone methylation by demethylimination
and demethylation. Nat Rev Mol Cell Biol 2007, 8:307–318.
20. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J,
Hansen KH, Salcini AE, Helin K: RBP2 belongs to a family of demethylases,
specific for tri-and dimethylated lysine 4 on histone 3. Cell 2007,
128:1063–1076.
21. Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA:
Histone demethylation mediated by the nuclear amine oxidase
homolog LSD1. Cell 2004, 119:941–953.
22. Tahiliani M, Mei P, Fang R, Leonor T, Rutenberg M, Shimizu F, Li J, Rao A,
Shi Y: The histone H3K4 demethylase SMCX links REST target genes to
X-linked mental retardation. Nature 2007, 447:601–605.
23. Frankenberg S, Smith L, Greenfield A, Zernicka-Goetz M: Novel gene
expression patterns along the proximo-distal axis of the mouse embryo
before gastrulation. BMC Dev Biol 2007, 7:8.
24. Madsen B, Spencer-Dene B, Poulsom R, Hall D, Lu PJ, Scott K, Shaw AT,
Burchell JM, Freemont P, Taylor-Papadimitriou J: Characterisation and
developmental expression of mouse Plu-1, a homologue of a human
nuclear protein (PLU-1) which is specifically up-regulated in breast
cancer. Gene Expr Patterns 2002, 2:275–282.
25. Dey BK, Stalker L, Schnerch A, Bhatia M, Taylor-Papidimitriou J, Wynder C:
The histone demethylase KDM5b/JARID1b plays a role in cell fate
decisions by blocking terminal differentiation. Mol Cell Biol 2008,
28:5312–5327.
26. Schmitz SU, Albert M, Malatesta M, Morey L, Johansen JV, Bak M, Tommerup
N, Abarrategui I, Helin K: Jarid1b targets genes regulating development
and is involved in neural differentiation. EMBO J 2011, 30:4586–4600.
27. Xie L, Pelz C, Wang W, Bashar A, Varlamova O, Shadle S, Impey S: KDM5B
regulates embryonic stem cell self-renewal and represses cryptic
intragenic transcription. EMBO J 2011, 30:1473–1484.
28. Kidder BL, Palmer S: Examination of transcriptional networks reveals an
important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem
cell maintenance. Genome Res 2010, 20:458–472.
29. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega
RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG,
Hogenesch JB: Large-scale analysis of the human and mouse
transcriptomes. Proc Natl Acad Sci USA 2002, 99:4465–4470.
30. Albert M, Schmitz SU, Kooistra SM, Malatesta M, Morales Torres C, Rekling JC,
Johansen JV, Abarrategui I, Helin K: The Histone demethylase Jarid1b ensures
faithful mouse development by protecting developmental genes from
aberrant H3K4me3. PLoS Genet 2013, 9:e1003461.
Kidder et al. Genome Biology 2014, 15:R32 Page 19 of 19
http://genomebiology.com/2014/15/2/R3231. Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M,
Beatson R, Scibetta AG, Burchell JM, Taylor-Papadimitriou J: PLU-1/JARID1B/
KDM5B is required for embryonic survival and contributes to cell
proliferation in the mammary gland and in ER + breast cancer cells.
Int J Oncol 2011, 38:1267–1277.
32. Kidder BL, Hu G, Yu ZX, Liu C, Zhao K: Extended self-renewal and
accelerated reprogramming in the absence of kdm5b. Mol Cell Biol 2013,
33:4793–4810.
33. Ram O, Goren A, Amit I, Shoresh N, Yosef N, Ernst J, Kellis M, Gymrek M,
Issner R, Coyne M, Durham T, Zhang X, Donaghey J, Epstein CB, Regev A,
Bernstein BE: Combinatorial patterning of chromatin regulators
uncovered by genome-wide location analysis in human cells. Cell 2011,
147:1628–1639.
34. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B,
Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL,
Lander ES: A bivalent chromatin structure marks key developmental
genes in embryonic stem cells. Cell 2006, 125:315–326.
35. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P,
Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A,
Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES,
Bernstein BE: Genome-wide maps of chromatin state in pluripotent and
lineage-committed cells. Nature 2007, 448:553–560.
36. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S,
Guenther MG, Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM,
Volkert TL, Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R,
Young RA: Connecting microRNA genes to the core transcriptional
regulatory circuitry of embryonic stem cells. Cell 2008, 134:521–533.
37. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA,
Young RA: c-Myc regulates transcriptional pause release. Cell 2010,
141:432–445.
38. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS,
Presser A, Nusbaum C, Xie X, Chi AS, Adli M, Kasif S, Ptaszek LM, Cowan CA,
Lander ES, Koseki H, Bernstein BE: Genomewide analysis of PRC1 and
PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet
2008, 4:e1000242.
39. Whyte WA, Bilodeau S, Orlando DA, Hoke HA, Frampton GM, Foster CT,
Cowley SM, Young RA: Enhancer decommissioning by LSD1 during
embryonic stem cell differentiation. Nature 2012, 482:221–225.
40. Newman AM, Cooper JB: AutoSOME: a clustering method for identifying
gene expression modules without prior knowledge of cluster number.
BMC Bioinformatics 2010, 11:117.
41. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M,
Wright C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA: ChIP-seq
accurately predicts tissue-specific activity of enhancers. Nature 2009,
457:854–858.
42. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ,
Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA,
Jaenisch R: Histone H3K27ac separates active from poised enhancers
and predicts developmental state. Proc Natl Acad Sci USA 2010,
107:21931–21936.
43. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J:
A unique chromatin signature uncovers early developmental enhancers
in humans. Nature 2011, 470:279–283.
44. Hawkins RD, Hon GC, Yang C, Antosiewicz-Bourget JE, Lee LK, Ngo QM,
Klugman S, Ching KA, Edsall LE, Ye Z, Kuan S, Yu P, Liu H, Zhang X, Green
RD, Lobanenkov VV, Stewart R, Thomson JA, Ren B: Dynamic chromatin
states in human ES cells reveal potential regulatory sequences and
genes involved in pluripotency. Cell Res 2011, 21:1393–1409.
45. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, Ding H,
Wylie JN, Pico AR, Capra JA, Erwin G, Kattman SJ, Keller GM, Srivastava D,
Levine SS, Pollard KS, Holloway AK, Boyer LA, Bruneau BG: Dynamic and
coordinated epigenetic regulation of developmental transitions in the
cardiac lineage. Cell 2012, 151:206–220.
46. Xiao S, Xie D, Cao X, Yu P, Xing X, Chen CC, Musselman M, Xie M, West FD,
Lewin HA, Wang T, Zhong S: Comparative epigenomic annotation of
regulatory DNA. Cell 2012, 149:1381–1392.
47. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines
differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000,
24:372–376.48. Foster CT, Dovey OM, Lezina L, Luo JL, Gant TW, Barlev N, Bradley A, Cowley
SM: Lysine-specific demethylase 1 regulates the embryonic
transcriptome and CoREST stability. Mol Cell Biol 2010, 30:4851–4863.
49. Wang J, Scully K, Zhu X, Cai L, Zhang J, Prefontaine GG, Krones A, Ohgi KA,
Zhu P, Garcia-Bassets I, Liu F, Taylor H, Lozach J, Jayes FL, Korach KS,
Glass CK, Fu XD, Rosenfeld MG: Opposing LSD1 complexes function in
developmental gene activation and repression programmes. Nature 2007,
446:882–887.
50. Adamo A, Sese B, Boue S, Castano J, Paramonov I, Barrero MJ, Izpisua
Belmonte JC: LSD1 regulates the balance between self-renewal and
differentiation in human embryonic stem cells. Nat Cell Biol 2011,
13:652–659.
51. Wang J, Hevi S, Kurash JK, Lei H, Gay F, Bajko J, Su H, Sun W, Chang H, Xu
G, Gaudet F, Li E, Chen T: The lysine demethylase LSD1 (KDM1) is
required for maintenance of global DNA methylation. Nat Genet 2009,
41:125–129.
52. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K: Genome-wide
mapping of HATs and HDACs reveals distinct functions in active and
inactive genes. Cell 2009, 138:1019–1031.
53. Wang A, Kurdistani SK, Grunstein M: Requirement of Hos2 histone
deacetylase for gene activity in yeast. Science 2002, 298:1412–1414.
54. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO,
Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE,
Ren B: Distinct and predictive chromatin signatures of transcriptional
promoters and enhancers in the human genome. Nat Genet 2007,
39:311–318.
55. Kidder BL, Palmer S: HDAC1 regulates pluripotency and lineage specific
transcriptional networks in embryonic and trophoblast stem cells.
Nucleic Acids Res 2012, 40:2925–2939.
56. Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-
efficient alignment of short DNA sequences to the human genome.
Genome Biol 2009, 10:R25.
57. Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W: A clustering approach
for identification of enriched domains from histone modification
ChIP-Seq data. Bioinformatics 2009, 25:1952–1958.
58. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C,
Myers RM, Brown M, Li W, Liu XS: Model-based analysis of ChIP-Seq (MACS).
Genome Biol 2008, 9:R137.
59. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B: Mapping and
quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008,
5:621–628.
60. Robinson MD, McCarthy DJ, Smyth GK: edgeR: a Bioconductor package for
differential expression analysis of digital gene expression data.
Bioinformatics 2009, 26:139–140.
61. Edgar R, Domrachev M, Lash AE: Gene Expression Omnibus: NCBI gene
expression and hybridization array data repository. Nucleic Acids Res 2002,
30:207–210.
62. GEO: KDM5B focuses H3K4 methylation near promoters and enhancers
during embryonic stem cell self-renewal and differentiation. [http://www.
ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53093]
doi:10.1186/gb-2014-15-2-r32
Cite this article as: Kidder et al.: KDM5B focuses H3K4 methylation near
promoters and enhancers during embryonic stem cell self-renewal and
differentiation. Genome Biology 2014 15:R32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
